The cardiovascular consequences of obstructive sleep apnea (OSA) in women may seem like a strange topic for the Womens’s Health NetWork featured lecture at CHEST 2016. This is mostly because OSA has historically been considered a disease of obese middle-aged men, and OSA is at least twice more common in men than in women. As a result of this, OSA is perceived as a “men’s disease.” This does not mean that there are no female patients with OSA, and this is a topic that requires further research.
Although women may experience similar symptoms of OSA as compared with men (eg, daytime sleepiness and snoring), the symptoms are oftentimes present with nonspecific symptomatology such as insomnia, restless legs, depression, or fatigue among others. The discrepancies between men and women in the prevalence and symptoms of OSA could be a result of women frequently being misdiagnosed or underdiagnosed.
We will explore these areas and more at the lecture “Cardiovascular Consequences of Obstructive Sleep Apnea in Women” that will take place from 2:45 pm to 4:15 pm on Tuesday, October 25, at CHEST 2016.
OSA is perceived as a “men’s disease.” This does not mean that there are no female patients with OSA, and this is a topic that requires further research.
Another area that will be explored is that although OSA in men has been shown to be an independent risk factor for death from all causes and development of cardiovascular outcomes; still the evidence of those associations among women is not clear. Interestingly, some studies suggest that women are not only unprotected from the cardiovascular consequences of OSA, but also these associations may be stronger that those observed in men.
So let’s help to change the perception that OSA is only a “men’s disease” by attending the Women’s Health NetWork lecture. This lecture is ideal for clinicians, allied health professionals, respiratory therapists, nurses, researchers, physiologists, and students.
I hope to see you in Los Angeles for CHEST 2016.
Tetyana Kendzerska, MD, PhD, is a Clinical Research Postdoctoral Fellow at the Institute for Clinical Evaluative Sciences (Toronto, Canada) and University of Toronto (Toronto, Canada). Dr. Kendzerska received her MD and training in internal medicine from Bukovinian State Medical University (Ukraine). She obtained her PhD degree in clinical epidemiology and health-care research (2014) and training in sleep medicine (2015) from the University of Toronto (Toronto, Canada).
Dr. Kendzerska has been involved in sleep research for over 5 years. Her research interests include epidemiology of sleep apnea, particularly relationship between sleep apnea and cardiovascular disease, mortality, diabetes, depression and cancer, compliance with continuous positive airway pressure treatment, survival analyses, predictive model development, and measurement of patient related outcomes.
Dr. Kendzerska is presenting “Cardiovascular Consequences of Obstructive Sleep Apnea in Women” at CHEST 2016 on Tuesday, October 25, from 2:45pm to 4:15pm. View the full program on our CHEST Events app.